학술논문

Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma
Document Type
Abstract
Source
In Blood 15 November 2022 140 Supplement 1:7174-7175
Subject
Language
ISSN
0006-4971